NYSE:AORT Artivion Q2 2026 Earnings Report $23.57 -0.89 (-3.65%) Closing price 07/8/2026 03:59 PM EasternExtended Trading$23.58 +0.01 (+0.06%) As of 04:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Artivion EPS ResultsActual EPSN/AConsensus EPS $0.13Beat/MissN/AOne Year Ago EPSN/AArtivion Revenue ResultsActual RevenueN/AExpected Revenue$120.02 millionBeat/MissN/AYoY Revenue GrowthN/AArtivion Announcement DetailsQuarterQ2 2026Date8/6/2026TimeAfter Market ClosesConference Call DateThursday, August 6, 2026Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile Artivion Earnings HeadlinesArtivion, Inc. (NYSE:AORT) Receives Average Recommendation of "Moderate Buy" from BrokeragesJuly 6 at 4:34 AM | americanbankingnews.comFDA approves Artivion’s AMDS device PMAJune 30, 2026 | yahoo.comRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change. | Porter & Company (Ad)Artivion: PMA Approval Supports Accelerating Growth And Margin ExpansionJune 30, 2026 | seekingalpha.comArtivion, Inc.: Artivion Announces U.S. FDA Approval of the AMDS Hybrid ProsthesisJune 29, 2026 | finanznachrichten.deArtivion Announces U.S. FDA Approval of the AMDS Hybrid ProsthesisJune 29, 2026 | prnewswire.comSee More Artivion Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Artivion? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Artivion and other key companies, straight to your email. Email Address About ArtivionArtivion (NYSE:AORT) (NYSE: AORT) is a global medical technology company that develops, manufactures and markets implantable tissue products and surgical devices for cardiac and vascular surgery. The company’s portfolio includes biologic implants derived from human and animal tissue, such as allografts and xenografts, as well as synthetic scaffolds and surgical adhesives. These products are designed to repair, reinforce or replace damaged cardiovascular and thoracic tissues during procedures such as aortic repair, heart valve surgery and vascular reconstruction. Originally founded in 1984 under the name CryoLife, the company rebranded as Artivion in early 2022 to reflect its broader mission in cardiovascular innovation. Headquartered in Kennesaw, Georgia, Artivion operates manufacturing and processing facilities in the United States and Europe, with commercial teams serving hospitals and surgical centers across North America, Latin America, Europe, the Middle East and Asia-Pacific. Its global footprint is supported by direct sales operations and distribution partnerships that deliver both off-the-shelf and custom tissue solutions to clinicians worldwide. Leadership at Artivion is focused on expanding the company’s product pipeline through research and development initiatives and strategic acquisitions. Under the direction of CEO Paul F. Le Gars, the company has pursued regulatory approvals across multiple markets and invested in next-generation tissue processing technologies. Through this combination of biologic innovation and device engineering, Artivion aims to address unmet clinical needs in cardiovascular surgery and improve patient outcomes over the long term. View Artivion ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Why Exxon Could Be the Market's Next Big Comeback StockWhy Penguin Solutions May Be the Smartest AI Infrastructure StockMeta Platforms’ Cloud Push: Growth Opportunity Versus AI ConcernsThese 3 Cash-Flow Stocks Give Investors More Than Just Growth PotentialDrone Stocks Are Down, But Defense Backlogs Tell a Different StoryGE Vernova’s Power Surge Turns the Grid Into an AI Trade2 Short Squeezes for Summer Speculation: What the Bears Are Getting Wrong Upcoming Earnings Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026)Wells Fargo & Company (7/14/2026)Citigroup (7/14/2026)Fastenal (7/14/2026)Cintas (7/15/2026)ASML (7/15/2026)Kinder Morgan (7/15/2026)BlackRock (7/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
